BackProMIS Neurosciences Overview
ProMIS Neurosciences Inc.

ProMIS Neurosciences Target Price

See ProMIS Neurosciences's analyst price targets ($25) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$12.6

Average Target Price

$25.25100.4% upside

4 analysts in the last 4 months

High: $33 | Low: $19

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-21Roth Capital$29130.2% upsideOpen
2026-07-28Chardan CapitalKeay Nakae$33161.9% upsideOpen
2026-07-27Chardan CapitalKeay Nakae$2058.7% upsideOpen
2026-07-07Roth Capital$1950.8% upsideOpen
2025-12-01H.C. Wainwright$1842.9% upsideOpen
2025-07-14H.C. WainwrightRaghuram Selvaraju$100693.7% upsideOpen

ProMIS Neurosciences (PMN) FAQ

As of the most recent data, PMN shows a target price of $25. Scroll down for historical charts and peer comparison views.

If ProMIS Neurosciences moved to the average analyst target of $25, shares would be roughly 100.4% higher than $12.6. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of ProMIS Neurosciences's earnings trajectory.

Besides this target price page, Stockcircle has ProMIS Neurosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $25) with ownership activity and broader fundamentals.

ProMIS Neurosciences's target price is $25; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.